Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLADRINA: Cladribine Tablets After Treatment With Natalizumab in MS
NCT04178005Phase 4Active, not recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2020
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cladribine in multiple sclerosis (MS), sponsored by UT Southwestern Medical Center. Started Feb 2020; status: active, not recruiting.
02
Drugs
cladribine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04178005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04178005.